Skip to main content
TipRanks
Go Ultimate75% OFF

Kalaris Therapeutics (KLRS) Ratios

399 Followers

Kalaris Therapeutics Ratios

KLRS's free cash flow for Q3 2026 was $-10.55M. For the 2026 fiscal year, KLRS's free cash flow was increased by $0.00 and operating cash flow was $-10.55M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio12.2322.630.850.696.69
Quick Ratio12.2322.630.850.696.69
Cash Ratio10.0922.580.800.545.33
Solvency Ratio-1.01-11.22-0.30-0.45-2.79
Operating Cash Flow Ratio-3.95-12.92-3.58-1.72-2.81
Short-Term Operating Cash Flow Coverage-121.420.000.000.00-16.13
Net Current Asset Value$ 75.89M$ 113.31M$ -45.02M$ -30.27M$ 192.02M
Leverage Ratios
Debt-to-Assets Ratio0.010.000.000.830.10
Debt-to-Equity Ratio0.020.000.00-0.110.13
Debt-to-Capital Ratio0.020.000.00-0.120.12
Long-Term Debt-to-Capital Ratio0.000.000.00-0.120.00
Financial Leverage Ratio1.541.05-0.07-0.131.27
Debt Service Coverage Ratio-23.870.00-20.40-64.89-25.92
Interest Coverage Ratio-31.980.00-19.60-59.600.00
Debt to Market Cap0.000.000.000.110.26
Interest Debt Per Share0.190.000.151.0511.01
Net Debt to EBITDA2.302.010.23-0.011.01
Profitability Margins
Gross Profit Margin0.00%0.00%0.00%0.00%0.00%
EBIT Margin0.00%0.00%0.00%0.00%0.00%
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin0.00%0.00%0.00%0.00%0.00%
Net Profit Margin0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT100.00%100.00%100.00%100.00%100.59%
EBT Per EBIT94.12%106.36%109.17%110.56%100.67%
Return on Assets (ROA)-35.68%-49.57%-441.01%-397.15%-60.00%
Return on Equity (ROE)-55.11%-51.87%32.65%51.15%-76.34%
Return on Capital Employed (ROCE)-41.20%-48.77%2210.84%781.58%-68.27%
Return on Invested Capital (ROIC)-41.08%-48.77%2210.84%781.58%-66.51%
Return on Tangible Assets-35.68%-49.57%-441.01%-397.15%-60.00%
Earnings Yield-33.71%-5.28%-35.62%-50.95%-690.76%
Efficiency Ratios
Receivables Turnover0.000.000.000.000.00
Payables Turnover0.010.000.000.000.13
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover0.000.000.000.000.00
Asset Turnover0.000.000.000.000.00
Working Capital Turnover Ratio0.000.000.000.000.00
Cash Conversion Cycle-35966.540.000.000.00-2732.11
Days of Sales Outstanding0.000.000.000.000.00
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding35966.540.000.000.002732.11
Operating Cycle0.000.000.000.000.00
Cash Flow Ratios
Operating Cash Flow Per Share-2.51-13.52-3.12-2.93-38.95
Free Cash Flow Per Share-2.53-13.52-3.12-2.93-38.96
Dividend Paid and CapEx Coverage Ratio-191.850.000.000.00-4089.19
Capital Expenditure Coverage Ratio-191.850.000.000.00-4089.19
Operating Cash Flow Coverage Ratio-26.500.000.00-3.01-3.54
Operating Cash Flow to Sales Ratio0.000.000.000.000.00
Free Cash Flow Yield-29.93%-6.08%-34.25%-32.17%-427.18%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-2.96-18.94-2.81-1.96-0.14
Price-to-Sales (P/S) Ratio0.000.000.000.000.00
Price-to-Book (P/B) Ratio1.639.82-0.92-1.000.11
Price-to-Free Cash Flow (P/FCF) Ratio-3.34-16.44-2.92-3.11-0.23
Price-to-Operating Cash Flow Ratio-3.36-16.44-2.92-3.11-0.23
Price-to-Earnings Growth (PEG) Ratio0.040.260.170.10-0.03
Enterprise Value Multiple-0.77-16.92-2.72-2.010.86
Enterprise Value32.25M994.49M38.09M30.59M-146.70M
EV to EBITDA-0.77-16.92-2.72-2.010.86
EV to Sales0.000.000.000.000.00
EV to Free Cash Flow-0.84-14.69-2.70-3.131.38
EV to Operating Cash Flow-0.84-14.69-2.70-3.131.38
Tangible Book Value Per Share5.1622.62-9.95-9.0882.53
Shareholders’ Equity Per Share5.1622.62-9.95-9.0882.53
Tax and Other Ratios
Effective Tax Rate0.000.000.000.00-0.01
Revenue Per Share0.000.000.000.000.00
Net Income Per Share-2.85-11.73-3.25-4.65-63.00
Tax Burden1.001.001.001.001.01
Interest Burden1.031.001.051.021.00
Research & Development to Revenue0.000.000.000.000.00
SG&A to Revenue0.000.000.000.000.00
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality0.881.150.960.630.62

Currency in USD